Skip to content

A prospective observational study of switching to single-inhaler triple combinations in patients with obstructive pulmonary disease

A prospective observational study of switching to single-inhaler triple combinations in patients with obstructive pulmonary disease - A prospective observational study of switching to single-inhaler triple combinations in patients with obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043389
Enrollment
50
Registered
2021-02-20
Start date
2021-02-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease and bronchial asthma

Interventions

None listed

Sponsors

Shizuoka General Hospital, respiratory medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. COPD or bronchial asthma patients who are planning to switch to single-inhaler triple therapy

Exclusion criteria

Exclusion criteria: 1. Patients with airway infection within 3 months 2. Patients who are contraindicative for single-inhaler triple therapy

Design outcomes

Primary

MeasureTime frame
A change of FEV1 after 8 weeks

Secondary

MeasureTime frame
A change of symptom score, FVC, IC, respiratory impedance, FeNO after 8 weeks

Countries

Japan

Contacts

Public ContactTaisuke Akamatsu

Shizuoka General Hospital Respiratory medicine

taisuke-akamatsu@i.shizuoka-pho.jp054-247-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026